LINC Q3 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹129.29 Cr
verified against source
Revenue YoY
5.8%
reported change
EBITDA
₹12.9 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Linc Limited reported Q3 FY26 operating income of 129.29 crore (5.8% YoY growth), reflecting a mixed operating environment with modest topline expansion. EBITDA stood at 12.9 crore with a 10% margin, though adjusted for one-time labor regulation costs, margins would have been ~10.7%. PAT of 6.77 crore (5.2% margin) contracted ~191bps YoY due to lower operating margins and 83 lakh JV losses. Cash generation remained healthy at 33.81 crore operating cash flow with a net free cash position of 10.14 crore. Key strategic initiatives—JV with Mitsubishi Pencil Japan (stable operations, encouraging product response), Turkish JV (operations commenced with gradual automation), Kenya subsidiary (momentum picking up), and Bangladesh JV (meaningful traction from next FY)—are progressing but remain in investment phase with moderating losses. Bengal manufacturing facility is delayed to Q1 FY27. New product launches in the below-5-rupee segment are driving volume but pressuring ASPs (down from 6.3 to 5 rupees). Risk: persistent margin pressure from product mix shifts toward mass segments and competitive pricing environment may limit near-term profitability recovery.
Colored figures show movement against the previous available record.
Guidance to track
- The manufacturing facility linked to Morris Korea subsidiary is slightly behind schedule and now expected to become operational by Q1 FY27 instead of earlier timeline.
- Marker products currently in 2-3 zones out of 5 domestic zones. Full pan-India rollout will be gradual based on capacity expansion to meet country-wide demand.
- Despite current ASP pressure from below-5-rupee segment launches, management's medium-term strategy prioritizes 10-rupee and above price segments, which should improve realizations over time.
Risks flagged
- Export revenue has remained flat at ~100 crore over the past 2-3 years despite management's stated focus on international expansion. Kenya subsidiary cannibalized direct export sales, and new market development requires longer sales cycles.
- Volume grew while revenue grew only 4-5.8% due to ASP compression from 6.3 to 5 rupees per unit. Management attributes this to product mix shifts toward mass segments, raising questions about sustainability of volume-driven growth.
- Despite being key growth drivers, JVs continued to report losses (83 lakh in Q3). Management expects moderation but gave no specific timeline for profitability, indicating ongoing drag on consolidated earnings.
- When asked if margins at ~10.7-11% would be maintained or face further pressure, management gave only qualitative directional guidance without specific targets, leaving uncertainty for investors.
Key quotes
- Over the last few quarters, our growth has been measured rather than aggressive, but this has been a conscious choice. Our focus has been on strengthening the product portfolio and building long-term growth drivers rather than chasing short-term expansion.
- There has been no price decrease which we have taken. There is a change in the composition of product. We realized that you know it is a big chunk of the market size and we've introduced few products at the 5 rupee MRP price segment and with increasing numbers in that price segment of course the ASP is expected to drop slightly.
- In export markets it takes slightly longer to build and develop those markets because the feet on street, the sales team are purely at our distributors' disposal.
Research modules